Navigation Links
Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
Date:12/3/2008

WORCESTER, Mass. Dec. 3, 2008 Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system. Having either too much or too little interleukin-12 may play a role in the development of many diseases, including some cancers and auto-immune disorders like Crohn's, psoriasis, and rheumatoid arthritis. In turn, modulating interleukin-12 levels could yield new therapies for those conditions.

In an effort to create a new and cost-effective method for producing interleukin-12 and make more of the scarce protein available for research and therapeutic development, a team of scientists at Worcester Polytechnic Institute's Life Sciences and Bioengineering Center (WPI) and the Arkansas Bioscience Institute at Arkansas State University (ABI) reports that hairy roots from genetically modified tobacco plants can be grown in a contained novel mist bioreactor system, yielding significant quantities of murine interleukin-12. A paper detailing the results of the study has been published early, online, by the journal Biotechnology and Bioengineering and will appear in the journal's printed edition early in 2009.

"We are very encouraged by the results of this study," says Pamela J. Weathers, PhD, professor of biology and biotechnology at WPI, co-author of the paper. "Interluekin-12 is a valuable protein and there just isn't enough available for biomedical research, let alone for therapeutic development. Our study shows that we can use plants to produce interleukin-12, and other therapeutic proteins, in a cost-effective controlled process."

The tobacco project is one of several emerging collaborative efforts between WPI and ABI. In the current study, tobacco plants were modified in the lab of Carole Cramer, PhD, ABI's executive director and co-author of the paper. Cramer's team successfully inserted into tobacco plants a mouse gene that directs the production of interleukin 12. Hairy root cultures fr
'/>"/>

Contact: Michael Cohen
mcohen@wpi.edu
508-868-4778
Worcester Polytechnic Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Novel Techniques Offers New Freedom to Patients with Parkinson's Disease, Epilepsy, Dystonia, and Tremor
2. USC researchers identify novel approach for suppressing prostate cancer development
3. Studies show novel device may enhance chemotherapy treatment in brain tumors
4. Labopharm to host webcast presentation on novel trazodone formulation for treatment of major depressive disorder
5. Labopharms NDA for Novel Trazodone Formulation accepted for review by FDA
6. E6 Ventures Invests in Novel Coatings Developer, Diamond Hard Surfaces Ltd
7. Novel imaging technique reveals brain abnormalities that may play key role in ADHD
8. Future Looks Bright For Non-Invasive Diagnosis Of Skin Cancer; Study Shows Novel Light Device Detects Cancerous Lesions From Normal Tissue
9. Novel IBS treatment developed at UB garners $8.5 million for seven-year clinical trial
10. Novel 4-drug combination proves safe for lung cancer treatment
11. Porter Novelli Named Agency of Record for Pharmavite(R) LLC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...eved to affect circadian rhythm, , ,... suggests that an internal body clock that goes on... bipolar disorder in children. , The finding r...of 152 children with bipolar disorder, which can m...40 children without the disorder. They linked vari...
(Date:11/27/2009)...v. 27 GSI Group Inc. (Pi...ecision technology products and semiconductor syst... Company,s shareholders has been scheduled for Fri... meeting will be announced in due course. As prev...on notice from Stephen Bershad, a holder of greate...
(Date:11/27/2009)...ch firm Replikins Ltd. today issued its latest bio... It shows that the lethality of the virus has drop...us,s current outbreak in the spring of 2009 to res...1). The H1N1 infectivity count, however, remains i...) November 27, 2009 -- Biotech firm Replikins Ltd....
(Date:11/27/2009)...27 The Gymboree Corporat... CFO/COO, will present at the NASDAQ OMX 23rd Inve...otel in London, England, on Wednesday, December 2,...e broadcast of The Gymboree Corporation,s presenta...ree.com, click on "Our Company" at the bottom of t...
(Date:11/27/2009)..., France, Nov. 27 Team Garmin-Slip...am dedicated to ethical sporting and developing th...today that it will become Team Garmin-Transitions ...sponsor of the team. Transitions Optical is the wo...fering the most advanced photochromic technology i...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3
...ults of their work linking mutations in BRAC2 gene...as published in the Journal of Medical Ethics. //M...velopment of breast and ovarian cancer in women ha...n BRAC2 mutations and increased risk of developmen...
...icking up infections like MRSA if they glucose in ...the recent issue of the journal Thorax.// The...ically ill patients in intensive care who required...re measured in their blood samples and lung secret...
...tterns associated with amusia or tone deafness in ...with other learning disorders like dyslexia. // ..., people who are tone deaf -- in scientific terms,...ired following injury to the brain. In an a...
...red to as meconium aspiration) occurs when a newbo...d during labor and delivery. Meconium is the m...ng pregnancy and is formed from ingested amniotic ...It can cause a partial or complete blockage of the...
...ncet, have proposed treating burst aneurysms with ...2002 the International Subarachnoid Aneurysm Trial...he minimally invasive technique, coiling, was more...ves a craniotomy and clipping of the aneurysm to s...
...ctrons have been implicated in a number of degener...mmunity has been trying hard to protect the body f...mentation with anti-oxidants, substances that coun...could help fight chronic disease. Numerous st...
Other Medicine News:Health News:Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions 2Health News:Platinum Coils To Replace Brain Surgery 2
(Date:11/27/2009)... , SALT LAKE CITY, Nov. 27 /PRNewswire-Firs...al Systems, Inc. (NYSE: VAR ), a premier supplie...ctors, will exhibit its full range of detectors at...ember 29 - December 3, 2009. Varian will also be ...lities as well as specialized cancer treatment tec...
(Date:11/26/2009)... , JOHANNESBURG, South Africa, Nov. 26 /PR...frica Company of the Year Award in the Generic Pha...uth Africa Limited. ,, (Logo: http://www.newsc...e Company of the Year Award, the following criteri...e against key competitors: growth strategy and imp...
(Date:11/25/2009)... , LOVELAND, Colo., Nov. 25 /PRNewswire-Fir... leading provider of advanced diagnostic and spe...ced today agreements with Roche Diagnostics Corpor...iliated consumables for the veterinary market. .../20000622/HESKALOGO ) ,, "Heska and Roche share...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Texas Doctor Files Case Pro Se in U S Supreme Court Against Insurance Giant on Integrity and Unethical Practices 58242 1Texas Doctor Files Case Pro Se in U S Supreme Court Against Insurance Giant on Integrity and Unethical Practices 58242 2Texas Doctor Files Case Pro Se in U S Supreme Court Against Insurance Giant on Integrity and Unethical Practices 58242 3New Cardiovascular Biomarker Available for Scientist in North America 5054 1New Cardiovascular Biomarker Available for Scientist in North America 5054 230th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 130th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 230th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 330th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 4
...Achieves Primary Endpoint Among High-Risk Infants ...n of Medically Attended,Outpatient RSV- Related Lo...7 /PRNewswire-FirstCall/ -- MedImmune, Inc.,today ...e trial,conducted for prevention of respiratory sy...b, the investigational monoclonal antibody,(MAb) a...
...D--(BUSINESS WIRE)--May 10, 2007 - An evaluation o...trogen therapy for the,treatment of vaginal atroph...as just been released by The North American,Menopa...ginal,estrogen for treatment of vaginal atrophy in...The North American Menopause Society,",the documen...
Other Medicine Technology:MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 2MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 3MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 4MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 5MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 6MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 7New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women 2New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women 3
Malis Needle Holders
Vascular Clamps RD-S
Vascular Clamps B-1
Micro Emulsifying Needles
Medicine Products: